Brief: Emergent Biosolutions Receives $64.5 Million Contract Modification For Bat® To Support U.S. Biodefense Strategy
28/05/2026 21:04
BRIEF-Emergent Biosolutions Receives $64.5 Million Contract Modification For Bat® To Support U.S. Biodefense Strategy May 28 (Reuters) - Emergent BioSolutions Inc EBS.N:
EMERGENT BIOSOLUTIONS RECEIVES $64.5 MILLION CONTRACT MODIFICATION FOR BAT® [BOTULISM ANTITOXIN HEPTAVALENT (A, B, C, D, E, F, G) – (EQUINE)] TO SUPPORT U.S. BIODEFENSE STRATEGY
Source text: ID:nGNXbGHDdQ
Further company coverage: EBS.N
((Reuters.Briefs@thomsonreuters.com;))